Showing 9411-9420 of 19217 results for "".
- Assessing the Impact of Environmental Exposures on Respiratory Health: Clinical Insightshttps://reachmd.com/news/assessing-the-impact-of-environmental-exposures-on-respiratory-health-clinical-insights/2484650/Large Danish nurses cohort links long-term black carbon exposure with higher incidence of asthma and COPD, even after accounting fo
- FDA Accelerates Approval of VOYXACT for IgA Nephropathy: A New Horizon in Treatmenthttps://reachmd.com/news/fda-accelerates-approval-of-voyxact-for-iga-nephropathy-a-new-horizon-in-treatment/2484653/VOYXACT (sibeprenlimab-szsi) received FDA accelerated approval to reduce proteinuria in adults with primary IgA nephropathy, the company reported
- UCLA Advances Kidney Transplantation: Delayed Donor Stem Cell Infusion Shows Promisehttps://reachmd.com/news/ucla-advances-kidney-transplantation-delayed-donor-stem-cell-infusion-shows-promise/2484624/A UCLA clinical trial reports that a delayed donor-derived hematopoietic stem cell infusion a
- Persistent Pulmonary and Vascular Inflammation After Mild–Moderate COVID-19 Detected by ¹⁸F-FDG PET/CThttps://reachmd.com/news/persistent-pulmonary-and-vascular-inflammation-after-mildmoderate-covid-19-detected-by-18f-fdg-petct/2484629/18F-FDG PET/CT shows persistent metabolic activity in the lungs and arterial walls months after mild–moderate COVID-19, identifying a subgroup that m
- Exploring GB-5001 Long-acting Injectable Donepezil: A New Frontier in Dementia Treatmenthttps://reachmd.com/news/exploring-gb-5001-long-acting-injectable-donepezil-a-new-frontier-in-dementia-treatment/2484621/GB-5001, a long‑acting injectable formulation of donepezil, produces extended systemic exposure and—if confirmed in patient trials—could materially improve adherence in dementia care. A Phase 1, open‑label, active‑controlled dose‑escalation study enrolled 50 healthy
- EACVI 2025: Advancements in Cardiovascular Imaging and Guideline Alignmenthttps://reachmd.com/news/eacvi-2025-cardiovascular-imaging-guidelines/2484604/The European Association of Cardiovascular Imaging (EAC
- Topical Tacrolimus in Breast Cancer Lymphedema Prevention: Insights from a Pilot Studyhttps://reachmd.com/news/topical-tacrolimus-in-breast-cancer-lymphedema-prevention-insights-from-a-pilot-study/2484602/In an open-label, nonrandomized pilot trial of 61 women, topical tacrolimus was evaluated as a preventive topical immunomodulator for breast cancer-related arm lymphedema after axillary lymph n
- Emerging Targets in Oncology: Advances in Pan-RAS Inhibitors and Translational Strategieshttps://reachmd.com/news/targets-oncology-pan-ras-inhibitors-translational-strategies/2484607/RMC-6236 has shown early pan‑RAS activity, with a recent review reporting preliminary disease‑control rates of approximately 85–87% across initial cohorts and signals of objective responses in
- AI Model Accurately Scores Psoriasis Severity from Clinical Imageshttps://reachmd.com/news/ai-model-accurately-scores-psoriasis-severity-from-clinical-images/2484588/A new study demonstrates the potential of artificial intelligence (AI) to improve the consistency and objectivity of psoriasis severity assessments based on 2D clinical images. Researchers for the study used the YOLOv8 deep lear
- Reevaluating Mean Arterial Pressure Targets in Vasodilatory Shock: Implications for Emergency Carehttps://reachmd.com/news/mean-arterial-pressure-targets-vasodilatory-shock/2484597/A recent systematic review and meta-analysis identified a mortality signal when comparing higher versus lower mean arterial pressure (MAP) targets in vasodilatory shock. Pool